On March 25, 2025, the Hangzhou Municipal Bureau of Economy and Information Technology released the "Public List of Hangzhou's First Batch of Innovative Small and Medium-sized Enterprises (SMEs) for 2025." Hangzhou Xunling Biotech Co., Ltd. was successfully included in this list, signifying official recognition of the company's technological innovation, development potential, and industry competitiveness.
This designation as an "Innovative SME" is not only a recognition of the company's past efforts but will also provide significant momentum for securing future policy support, facilitating financing connections, and expanding market reach.
Moving forward, Xunling Biotech will continue to deepen its technological innovation, accelerate the translation of research into practical applications, and further enhance its core competitiveness. We are committed to advancing toward our goal of becoming a "Specialized, Refined, Unique, and Innovative" enterprise, contributing to the high-quality development of the precision diagnostics industry.